|
|||||
|
|
Risk of rhabdomyolysis from 5‐α reductase inhibitors |
|
| Authors: | Blayne Welk Eric McArthur Michael Ordon Jade Dirk Stephanie Dixon Amit X. Garg |
| Affiliation: | 1. Department of Surgery, Western University, London, ON, Canada;2. Institute for Clinical Evaluative Sciences, London, ON, Canada;3. Department of Epidemiology and Biostatistics, Western University, London, ON, Canada;4. Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada;5. Department of Medicine, Western University, London, ON, Canada |
| Abstract: | |
| Keywords: | 5‐α reductase inhibitors benign prostatic hyperplasia dutasteride finasteride pharmacoepidemiology rhabdomyolysis |